Key result
Device closure cuts recurrent stroke rate ~59% vs. medical therapy.
Meta-Analysis (n=3,740)
Yes
Answers are grounded in this paper and cite their sources.
Supports device closure for secondary stroke prevention; reinforces superiority over medical therapy in pooled randomized trial data.
3
No takes yet. Share an insight, caveat, or question.
Yuji Ueno (2025) conducted a meta-analysis in Cryptogenic stroke (n=3,740). Device closure vs. Medical therapy (aspirin) was evaluated on Recurrent stroke rate (HR 0.41, 95% CI 0.28-0.60, p=<0.001). Device closure reduced the annual recurrent stroke rate to 0.47% compared to 1.09% with medical therapy, with a.41.
Synapse has enriched 10 related papers. Consider them for comparative context: